<DOC>
	<DOC>NCT00234897</DOC>
	<brief_summary>The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid arthritis focusing on subject-reported outcomes and early response to treatment</brief_summary>
	<brief_title>Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Subject was age 18 or older and in good health (Investigator discretion) with a recent stable medical history. Subject, based on assessment of investigator, meets the definition of active RA Subject considered by the investigator, for any reason, to be an unsuitable candidate for the study Female subject who is pregnant or breastfeeding or considering becoming pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>adalimumab</keyword>
	<keyword>rheumatoid arthritis</keyword>
</DOC>